A prognostic indicator of survival in metastatic colorectal cancer patients in the era of molecular-targeted agents: the modified Glasgow Prognostic Score

Oncology. 2014;86(1):44-5. doi: 10.1159/000356879. Epub 2013 Dec 20.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adenocarcinoma / mortality*
  • Biomarkers, Tumor / analysis*
  • Colorectal Neoplasms / mortality*
  • Combined Modality Therapy / adverse effects*
  • Female
  • Humans
  • Inflammation / etiology*
  • Male

Substances

  • Biomarkers, Tumor